OTC Markets OTCPK - Delayed Quote USD

Kelyniam Global, Inc. (KLYG)

0.1400
+0.0051
+(3.78%)
At close: May 29 at 10:42:18 AM EDT
Loading Chart for KLYG
  • Previous Close 0.1349
  • Open 0.1186
  • Bid --
  • Ask --
  • Day's Range 0.1186 - 0.1500
  • 52 Week Range 0.0600 - 0.3900
  • Volume 11,550
  • Avg. Volume 25,990
  • Market Cap (intraday) 6.961M
  • Beta (5Y Monthly) -1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Collinsville, Connecticut.

www.kelyniam.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KLYG

更多內容

Performance Overview: KLYG

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

KLYG
17.65%
S&P 500 (^GSPC)
0.51%

1-Year Return

KLYG
133.33%
S&P 500 (^GSPC)
12.92%

3-Year Return

KLYG
27.27%
S&P 500 (^GSPC)
42.17%

5-Year Return

KLYG
100.00%
S&P 500 (^GSPC)
94.19%

比較: KLYG

選擇以關鍵表現數據分析類似公司;最多可選擇 4 個股份。

Statistics: KLYG

更多內容

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    6.96M

  • Enterprise Value

    6.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.18%

  • Return on Assets (ttm)

    -9.25%

  • Return on Equity (ttm)

    -31.64%

  • Revenue (ttm)

    2.67M

  • Net Income Avi to Common (ttm)

    -218.47k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.07k

  • Total Debt/Equity (mrq)

    101.97%

  • Levered Free Cash Flow (ttm)

    98.32k

Research Analysis: KLYG

更多內容

Company Insights: KLYG

研究報告: KLYG

更多內容

People Also Watch